DSGN

MKT CAP:$949M

Design Therapeutics Inc

Market Cap

$949M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$13.52+$4.42 (+48.57%)

Jul 15, 2026

52W High $15.7952W Low $3.82

Company Details

Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its Gene...

Leadership

Pratik Shah Ph.D.Founder

Co-Founder, President, CEO, Principal Financial Officer & Executive Chairperson

Sean Jeffries Ph.D.

Chief Operating Officer

Chris M. Storgard M.D.

Chief Medical Officer

Aseem Z. Ansari Ph.D.Founder

Co-Founder & Scientific Advisor

Julie D. Burgess CPA

Chief Accounting Officer

Doane Chilcoat Ph.D.

Chief Technology Officer

Mustapha Parekh

General Counsel

Tadimeti S. Rao Ph.D.

Chief Scientific Officer

Jim Kerr

Chief of Manufacturing & Product Development

Chengzhi Zhang Ph.D.

Chief Chemist

IPO Date

Mar 26, 2021

Website

www.designtx.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$70M

EPS (Diluted)

Free Cash Flow

-$54M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee